180 related articles for article (PubMed ID: 22249100)
1. Immunoprotective role of indoleamine 2,3-dioxygenase in engraftment of allogenic skin substitute in wound healing.
Bahar MA; Nabai L; Ghahary A
J Burn Care Res; 2012; 33(3):364-70. PubMed ID: 22249100
[TBL] [Abstract][Full Text] [Related]
2. Local expression of indoleamine 2,3-dioxygenase suppresses T-cell-mediated rejection of an engineered bilayer skin substitute.
Forouzandeh F; Jalili RB; Hartwell RV; Allan SE; Boyce S; Supp D; Ghahary A
Wound Repair Regen; 2010; 18(6):614-23. PubMed ID: 20955343
[TBL] [Abstract][Full Text] [Related]
3. Local expression of indoleamine 2,3-dioxygenase protects engraftment of xenogeneic skin substitute.
Li Y; Tredget EE; Ghaffari A; Lin X; Kilani RT; Ghahary A
J Invest Dermatol; 2006 Jan; 126(1):128-36. PubMed ID: 16417228
[TBL] [Abstract][Full Text] [Related]
4. Cell surface expression of MHC class I antigen is suppressed in indoleamine 2,3-dioxygenase genetically modified keratinocytes: implications in allogeneic skin substitute engraftment.
Li Y; Tredget EE; Ghahary A
Hum Immunol; 2004 Feb; 65(2):114-23. PubMed ID: 14969766
[TBL] [Abstract][Full Text] [Related]
5. Human fetal skin fibroblasts: Extremely potent and allogenic candidates for treatment of diabetic wounds.
Larijani B; Ghahari A; Warnock GL; Aghayan HR; Goodarzi P; Falahzadeh K; Arjmand B
Med Hypotheses; 2015 Jun; 84(6):577-9. PubMed ID: 25784640
[TBL] [Abstract][Full Text] [Related]
6. Immunological role of indoleamine 2,3-dioxygenase in rat liver allograft rejection and tolerance.
Lin YC; Chen CL; Nakano T; Goto S; Kao YH; Hsu LW; Lai CY; Jawan B; Cheng YF; Tateno C; Yoshizato K
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e243-50. PubMed ID: 17645734
[TBL] [Abstract][Full Text] [Related]
7. Prolonged skin grafts survival time by IFN-γ in allogeneic skin transplantation model during acute rejection through IFN-γ/STAT3/IDO pathway in epidermal layer.
Zhang Y; Wang Y; Wu G; Zhang W; Wang X; Cai W; Zhang J; Han S; Li Y; Bai X; Shi J; Su L; Hu D
Biochem Biophys Res Commun; 2018 Feb; 496(2):436-442. PubMed ID: 29288671
[TBL] [Abstract][Full Text] [Related]
8. CD11b(+) cells in donor-specific transfusion prolonged allogenic skin graft survival through indoleamine 2,3-dioxygenase.
Ikemoto T; Takita M; Levy MF; Shimada M; Naziruddin B
Cell Immunol; 2013; 283(1-2):81-90. PubMed ID: 23933136
[TBL] [Abstract][Full Text] [Related]
9. Indoleamine 2,3-dioxygenase and foxp3 expression in skin rejection of human hand allografts.
Hautz T; Brandacher G; Zelger B; Müller HG; Lee AW; Fuchs D; Margreiter R; Schneeberger S
Transplant Proc; 2009 Mar; 41(2):509-12. PubMed ID: 19328914
[TBL] [Abstract][Full Text] [Related]
10. Burn wound healing and skin substitutes.
Shakespeare P
Burns; 2001 Aug; 27(5):517-22. PubMed ID: 11451610
[TBL] [Abstract][Full Text] [Related]
11. StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial.
Centanni JM; Straseski JA; Wicks A; Hank JA; Rasmussen CA; Lokuta MA; Schurr MJ; Foster KN; Faucher LD; Caruso DM; Comer AR; Allen-Hoffmann BL
Ann Surg; 2011 Apr; 253(4):672-83. PubMed ID: 21475006
[TBL] [Abstract][Full Text] [Related]
12. An in-situ forming skin substitute improves healing outcome in a hypertrophic scar model.
Hartwell R; Poormasjedi-Meibod MS; Chavez-Munoz C; Jalili RB; Hossenini-Tabatabaei A; Ghahary A
Tissue Eng Part A; 2015 Mar; 21(5-6):1085-94. PubMed ID: 25412924
[TBL] [Abstract][Full Text] [Related]
13. Application of an indoleamine 2,3-dioxygenase-expressing skin substitute improves scar formation in a fibrotic animal model.
Chavez-Munoz C; Hartwell R; Jalili RB; Carr M; Kilani RT; Jafarnejad SM; Rahmani-Neishabour E; Forouzandeh F; Boyce ST; Ghahary A
J Invest Dermatol; 2012 May; 132(5):1501-5. PubMed ID: 22297642
[No Abstract] [Full Text] [Related]
14. Full-thickness skin wound healing using autologous keratinocytes and dermal fibroblasts with fibrin: bilayered versus single-layered substitute.
Idrus RB; Rameli MA; Low KC; Law JX; Chua KH; Latiff MB; Saim AB
Adv Skin Wound Care; 2014 Apr; 27(4):171-80. PubMed ID: 24637651
[TBL] [Abstract][Full Text] [Related]
15. Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression.
Beutelspacher SC; Pillai R; Watson MP; Tan PH; Tsang J; McClure MO; George AJ; Larkin DF
Eur J Immunol; 2006 Mar; 36(3):690-700. PubMed ID: 16482510
[TBL] [Abstract][Full Text] [Related]
16. Immunoprotection and Functional Improvement of Allogeneic Islets in Diabetic Mice, Using a Stable Indoleamine 2,3-Dioxygenase Producing Scaffold.
Hosseini-Tabatabaei A; Jalili RB; Khosravi-Maharlooei M; Hartwell R; Kilani RT; Zhang Y; Ghahary A
Transplantation; 2015 Jul; 99(7):1341-8. PubMed ID: 25769070
[TBL] [Abstract][Full Text] [Related]
17. Expression of indoleamine 2,3-dioxygenase in dermal fibroblasts functions as a local immunosuppressive factor.
Ghahary A; Li Y; Tredget EE; Kilani RT; Iwashina T; Karami A; Lin X
J Invest Dermatol; 2004 Apr; 122(4):953-64. PubMed ID: 15102086
[TBL] [Abstract][Full Text] [Related]
18. Randomized, Paired-Site Comparison of Autologous Engineered Skin Substitutes and Split-Thickness Skin Graft for Closure of Extensive, Full-Thickness Burns.
Boyce ST; Simpson PS; Rieman MT; Warner PM; Yakuboff KP; Bailey JK; Nelson JK; Fowler LA; Kagan RJ
J Burn Care Res; 2017; 38(2):61-70. PubMed ID: 27404165
[TBL] [Abstract][Full Text] [Related]
19. IDO expressing dendritic cells suppress allograft rejection of small bowel transplantation in mice by expansion of Foxp3+ regulatory T cells.
Xie FT; Cao JS; Zhao J; Yu Y; Qi F; Dai XC
Transpl Immunol; 2015 Oct; 33(2):69-77. PubMed ID: 26002283
[TBL] [Abstract][Full Text] [Related]
20. The immunoregulatory function of indoleamine 2, 3 dioxygenase and its application in allotransplantation.
Jalili RB; Forouzandeh F; Bahar MA; Ghahary A
Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):167-79. PubMed ID: 18094439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
